NeuroRx Initiates Pivotal Study for NRX-101, a Breakthrough Designation Therapy Targeting Suicidal Bipolar Depression | Small Molecules | News Channels - PipelineReview.com

Submitted by Anonymous (not verified) on Tue, 07/09/2019 - 18:21

NeuroRx Initiates Pivotal Study for NRX-101, a Breakthrough Designation Therapy Targeting Suicidal Bipolar Depression | Small Molecules | News Channels  PipelineReview.comNeuroRx Initiates Pivotal Study for NRX-101, a Breakthrough Designation Therapy Targeting Suicidal Bipolar Depression.